Mitchell E Hughes

6PUBLICATIONS
37CO-AUTHORS
Haematological tumoursImmunology not elsewhere classifiedApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Pharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 12, 2023
High-grade B-cell lymphoma, not otherwise specified: a multi-institutional retrospective study.

Adam S Zayac, Daniel J Landsburg, Mitchell E Hughes

|Mar 17, 2023
Pemigatinib for the treatment of myeloid/lymphoid neoplasms with FGFR1 rearrangement.

Craig W Freyer, Mitchell E Hughes, Alison Carulli

|Apr 26, 2022
New and emerging therapies for the treatment of relapsed/refractory diffuse large B-cell lymphoma.

Donald C Moore, Matthew R Peery, Katherine A Tobon

|Jan 17, 2022
Addressing the Challenges of Novel Oncology and Hematology Treatments Across Sites of Care: Specialty Pharmacy Solutions.

Houston Wyatt, Autumn D Zuckerman, Mitchell E Hughes

|Jan 18, 2019
Outcomes of patients with relapsed/refractory double-expressor B-cell lymphoma treated with ibrutinib monotherapy.

Daniel J Landsburg, Mitchell E Hughes, Alexa Koike

Pageof 1